» Articles » PMID: 32228795

Typhoid Outbreaks, 1989-2018: Implications for Prevention and Control

Overview
Specialty Tropical Medicine
Date 2020 Apr 2
PMID 32228795
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Typhoid fever remains an important public health problem in low- and middle-income countries, with large outbreaks reported from Africa and Asia. Although the WHO recommends typhoid vaccination for control of confirmed outbreaks, there are limited data on the epidemiologic characteristics of outbreaks to inform vaccine use in outbreak settings. We conducted a literature review for typhoid outbreaks published since 1990. We found 47 publications describing 45,215 cases in outbreaks occurring in 25 countries from 1989 through 2018. Outbreak characteristics varied considerably by WHO region, with median outbreak size ranging from 12 to 1,101 cases, median duration from 23 to 140 days, and median case fatality ratio from 0% to 1%. The largest number of outbreaks occurred in WHO Southeast Asia, 13 (28%), and African regions, 12 (26%). Among 43 outbreaks reporting a mode of disease transmission, 24 (56%) were waterborne, 17 (40%) were foodborne, and two (5%) were by direct contact transmission. Among the 34 outbreaks with antimicrobial resistance data, 11 (32%) reported Typhi non-susceptible to ciprofloxacin, 16 (47%) reported multidrug-resistant (MDR) strains, and one reported extensively drug-resistant strains. Our review showed a longer median duration of outbreaks caused by MDR strains (148 days versus 34 days for susceptible strains), although this difference was not statistically significant. Control strategies focused on water, sanitation, and food safety, with vaccine use described in only six (13%) outbreaks. As typhoid conjugate vaccines become more widely used, their potential role and impact in outbreak control warrant further evaluation.

Citing Articles

Time series data on typhoid fever incidence during outbreaks from 2000 to 2022.

Koh D, Duong M, Kipshidze N, Pitzer V, Kim J Sci Data. 2025; 12(1):94.

PMID: 39821093 PMC: 11739417. DOI: 10.1038/s41597-024-04289-7.


Locally acquired typhoid fever outbreak linked to chronic carriage in Ottawa, Canada, 2018-2022.

Zhang J, Jolly A, Nguyen T, Taha M, Lee C, Corbeil A Can Commun Dis Rep. 2024; 50(11):412-418.

PMID: 39525079 PMC: 11542676. DOI: 10.14745/ccdr.v50i11a05.


Bacterial profile and antibiotic susceptibility patterns in patients with secondary peritonitis: a cross-sectional study in Uganda.

Godefroy N, Muhumuza J, Molen S, Waziri M, Kagenderezo B, Vahwere B Perioper Med (Lond). 2024; 13(1):62.

PMID: 38915124 PMC: 11197276. DOI: 10.1186/s13741-024-00425-4.


Typhoid fever.

Meiring J, Khanam F, Basnyat B, Charles R, Crump J, Debellut F Nat Rev Dis Primers. 2023; 9(1):71.

PMID: 38097589 DOI: 10.1038/s41572-023-00480-z.


Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.

Phillips M, Antillon M, Bilcke J, Bar-Zeev N, Limani F, Debellut F BMC Infect Dis. 2023; 23(1):143.

PMID: 36890448 PMC: 9993384. DOI: 10.1186/s12879-023-08105-2.


References
1.
Bayram Y, Guducuoglu H, Otlu B, Aypak C, Gursoy N, Uluc H . Epidemiological characteristics and molecular typing of Salmonella enterica serovar Typhi during a waterborne outbreak in Eastern Anatolia. Ann Trop Med Parasitol. 2011; 105(5):359-65. PMC: 4089787. DOI: 10.1179/1364859411Y.0000000024. View

2.
Antillon M, Warren J, Crawford F, Weinberger D, Kurum E, Pak G . The burden of typhoid fever in low- and middle-income countries: A meta-regression approach. PLoS Negl Trop Dis. 2017; 11(2):e0005376. PMC: 5344533. DOI: 10.1371/journal.pntd.0005376. View

3.
Antillon M, Bilcke J, Paltiel A, Pitzer V . Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine. 2017; 35(27):3506-3514. PMC: 5462484. DOI: 10.1016/j.vaccine.2017.05.001. View

4.
Lo N, Gupta R, Stanaway J, Garrett D, Bogoch I, Luby S . Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study. J Infect Dis. 2018; 218(suppl_4):S232-S242. PMC: 6226717. DOI: 10.1093/infdis/jix598. View

5.
Kim J, Mogasale V, Im J, Ramani E, Marks F . Updated estimates of typhoid fever burden in sub-Saharan Africa. Lancet Glob Health. 2017; 5(10):e969. DOI: 10.1016/S2214-109X(17)30328-5. View